Patients make treatment decisions together with their doctor. However, not all patients have well-documented and understandable information about the possible treatment options. We strive for patients to make only informed decisions.
Filtering, translating and educating
Our team is independent and open-minded. We consult reliable sources (NCI, UpToDate, MSKcc, cam-cancer, a.o.) and guidelines (NCCN, ESMO) to inform about treatment options. We filter and translate scientific data and results into a language understandable to patients and their families. We also help patients structure and comprehend complex information about registered and complementary or alternative therapies so that it can be used in treatment discussions with the attending physician.
We can help!
The Anticancer Fund personally answers all therapy-related questions from patients and their families. It is crucial to clearly formulate your question and describe which type of information you would like us to provide you with.
To improve our patient services, we deeply appreciate your feedback about information provided to you by the Anticancer Fund.
What kind of information do we provide?
We provide non-judgmental, evidence-based information about:
specific types of cancer,
available treatment options,
treatment options suggested by international guidelines,
experimental treatment options and clinical trials,
treatment centres and specialists across borders,
and we can provide scientific evidence of the complementary treatment you are considering.
My Cancer Navigator
My Cancer Navigator is an information service for cancer patients.
We inform – we do not advise
The Anticancer Fund does not provide medical advice and the information provided does not replace a medical consultation. Treatment decisions must always be made after consultation with the attending physician.
Our views on treating cancer
We invest in the most promising research to make measurable progress in the fight against cancer.
We strive to improve survival and quality of life, financial return is not within the scope of our activities.
We identify untapped potential in cancer research leading to pragmatic solutions for patients in need.
We seek impact and we invest our resources where we believe we can make the most progress.
Every cancer deserves the same attention, regardless of prevalence or profitability.